The Insider Activity Of Nutex Health Inc. (NUTX) Is Worth Monitoring


Nutex Health Inc. (NASDAQ:NUTX) finished Friday with a subtraction of -$0.09 to close at $1.90, a downside of -4.52 percent. An average of 976,240 shares of common stock have been traded in the last five days. There was a fall of -$0.2200 in the past week, and it reached a new high 7 times over the past 12 months. The last 20 days have seen an average of 2,997,335 shares traded, while the 50-day average volume stands at 2,878,064.

NUTX stock has increased by 22.58% in the last month. The company shares reached their 1-month lowest point of $1.4700 on 12/01/22. With the stock rallying to its 52-week high on 04/04/22, shares of the company touched a low of $0.50 and a high of $52.80 in 52 weeks. It has reached a new high 6 times so far this year and lost -53.88% or -$2.2200 in price. In spite of this, the price is down -96.40% from the 52-week high.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Insider Transactions

NUTX stock investors should be aware that Nutex Health Inc. (NUTX) stock had its last reported insider trading activity 18 days ago on Dec 13. In this transaction, the insider spent $90,560. 10% Owner, Premier Macy Management Holdin, disposed of 125,498 shares at a price of $2.21 on Dec 12. The insider now owns more than $276,773 worth of shares.

Valuation Metrics

Nutex Health Inc. (NUTX) stock’s beta is 0.51. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 7.34, the price-to-book (PB) ratio at 11.18.

Financial Health

The quick ratio of Nutex Health Inc. for the recent quarter was 2.40, and the current ratio was 2.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 2.08 and a total debt to equity ratio of 2.17 for the recent quarter. Its gross profit as reported stood at $4.15 million compared to revenue of $18.79 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Nutex Health Inc.’s return on assets was -108.10%.

Earnings Surprise

For the recent quarter, Nutex Health Inc. had $24.69 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$422.52 million in the quarter, while revenues of -$19.4 million were grew 99.57%. Shareholders own equity worth $649.77 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Nutex Health Inc. (NUTX) price momentum. RSI 9-day as of the close on 30 December was 50.10%, suggesting the stock is Neutral, with historical volatility in this time frame at 107.94%.

As of today, NUTX’s price is $1.9620 -10.38% or -$0.2200 from its 5-day moving average. NUTX is currently trading +4.97% higher than its 20-day SMA and -51.65% lower than its 100-day SMA. However, the stock’s current price level is +180.40% above the SMA50 and -52.50% below the SMA200.

The stochastic %K and %D were 42.91% and 42.53%, respectively, and the average true range (ATR) was 0.2510. With the 14-day stochastic at 35.63% and the average true range at 0.2545, the RSI (14) stands at 53.24%. The stock has reached -0.0011 on the 9-day MACD Oscillator while the 14-day reading was at 0.0255.


Please enter your comment!
Please enter your name here